NRX PHARMACEUTICALS INC
(NASDAQ: NRXP)
NRX Pharmaceuticals, Inc. is a clinical-stage small molecule pharmaceutical company. It engages in developing of novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company was founded on September 18, 2017 and is headquartered in Wilmington, DE.
3.510
+0.370
(+11.78%)
Range
3.160 - 3.640
(15.19%)
Open
-
Previous Close
3.140
Bid Price
-
Bid Volume
8
Ask Price
0.740
Ask Volume
9
Volume
278,922
Value
-
Remark
Delayed prices. Updated at 27 Apr 2024 03:59.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
